Literature DB >> 30283626

Adverse drug reaction reporting in a large tertiary hospital in Saudi Arabia: results of an incentive strategy.

Sheraz Ali1, Oluwaseun Egunsola2, Dalal Salem Al-Dossari3, Ibrahim Abdulaziz Al-Zaagi3.   

Abstract

BACKGROUND: Underreporting is a common problem with spontaneous adverse drug reaction (ADR) reporting. In this study, we aim to describe the reporting of ADRs in a tertiary hospital and determine the effect of incentives to healthcare professionals on ADR reporting.
METHODS: In this interventional study, a time series analysis was used to determine the effect of incentives on ADR reporting in a tertiary hospital between 2015 and 2016. The incentive strategy included public commendation of health care providers and nomination for a monthly award.
RESULTS: A total of 967 ADRs were reported over a 2-year period. After the introduction of incentives in January 2016, the number of ADR reports per month increased by 40.6 (95% confidence interval: 26.1-55.1). The proportion of serious ADRs reported was significantly higher in 2016 (39/800) than 2015 (0/167) (p < 0.001). In 2016, there was a significant association between profession and serious ADR reporting (p < 0.001). A total of 14/21 ADRs (66.7%) reported by physicians in 2016 were serious compared with 20/700 (2.9%) reported by clinical pharmacists and 5/72 (6.9%) by nurses.
CONCLUSIONS: ADR reporting was improved by providing incentives, including commendation and reward, to healthcare professionals.

Entities:  

Keywords:  Middle-East; drug safety; pharmacovigilance

Year:  2018        PMID: 30283626      PMCID: PMC6166318          DOI: 10.1177/2042098618790209

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  14 in total

1.  Segmented regression analysis of interrupted time series studies in medication use research.

Authors:  A K Wagner; S B Soumerai; F Zhang; D Ross-Degnan
Journal:  J Clin Pharm Ther       Date:  2002-08       Impact factor: 2.512

2.  An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.

Authors:  Consuelo Pedrós; Antoni Vallano; Gloria Cereza; Gemma Mendoza-Aran; Antònia Agustí; Cristina Aguilera; Immaculada Danés; Xavier Vidal; Josep M Arnau
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system.

Authors:  A Alvarez-Requejo; A Carvajal; B Bégaud; Y Moride; T Vega; L H Arias
Journal:  Eur J Clin Pharmacol       Date:  1998-08       Impact factor: 2.953

4.  Analysis of medication errors at a large tertiary care hospital in Saudi Arabia: a retrospective analysis.

Authors:  Sheraz Ali; Nourah Ibrahim Aboheimed; Ibrahim Abdulaziz Al-Zaagi; Dalal Salem Al-Dossari
Journal:  Int J Clin Pharm       Date:  2017-07-26

Review 5.  Strategies to improve adverse drug reaction reporting: a critical and systematic review.

Authors:  Cristian Gonzalez-Gonzalez; Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Medication safety practices in hospitals: A national survey in Saudi Arabia.

Authors:  Hisham Aljadhey; Abdulaziz Alhossan; Khalid Alburikan; Mansour Adam; Michael D Murray; David W Bates
Journal:  Saudi Pharm J       Date:  2012-08-08       Impact factor: 4.330

8.  Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study.

Authors:  Hisham Aljadhey; Mansour A Mahmoud; Yusuf Ahmed; Razia Sultana; Salah Zouein; Sulafah Alshanawani; Ahmed Mayet; Mashael K Alshaikh; Nora Kalagi; Esraa Al Tawil; Abdul Rahman El Kinge; Abdulmajid Arwadi; Maha Alyahya; Michael D Murray; David Bates
Journal:  BMJ Open       Date:  2016-07-12       Impact factor: 2.692

9.  Knowledge and Attitude of Health-Care Professionals Toward Adverse Drug Reactions Reporting at King Saud Medical City.

Authors:  Khaja Moinuddin; Sheraz Ali; Amal Qadri Al-Aqqad; Sara Osama Salem; Maram Abdullah Al-Dossari; Abdullah Mohammad Ananzeh; Jaffer Bin Baqar
Journal:  J Pharm Bioallied Sci       Date:  2018 Jan-Mar

10.  Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.

Authors:  Kazeem A Oshikoya; Jacob O Awobusuyi
Journal:  BMC Clin Pharmacol       Date:  2009-08-11
View more
  5 in total

1.  The comparative assessment of awareness, perspective, and basic practice skills about the Saudi pharmacovigilance system among students of different health-care professionals of a Saudi Female University.

Authors:  Asmatanzeem Bepari; Rasha Assad Assiri; Maya Abdullah AlYahya; Shaden Jamaan AlGhamdi; Amal Mohammed AlGhamdi; Afrah Asaad AlOnazi
Journal:  Saudi Pharm J       Date:  2020-06-12       Impact factor: 4.330

2.  Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study.

Authors:  Kidu Gidey; Mohammedamin Seifu; Berhane Yohannes Hailu; Solomon Weldegebreal Asgedom; Yirga Legesse Niriayo
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

3.  Retrospective Assessment of the Reporting of Adverse Drug Reactions in a Malaysian Clinical Training Center: A Short Communication.

Authors:  Ramadan M Elkalmi; Mohamed Hassan Elnaem; Nurmisaliza Mohd Sapar; Ali Blebil
Journal:  J Pharm Bioallied Sci       Date:  2021-11-24

4.  Medication Misadventures Among COVID-19 Patients in Saudi Arabia.

Authors:  Dlal Almazrou; Oluwaseun Egunsola; Sheraz Ali; Amal Bagalb
Journal:  Cureus       Date:  2021-06-08

5.  Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator.

Authors:  Paul N Deslandes; Robert Bracchi; Karen Jones; Kath E Haines; Emma Carey; Alana Adams; Jenna Walker; Alison Thomas; Philip A Routledge
Journal:  Br J Clin Pharmacol       Date:  2022-04-07       Impact factor: 3.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.